Accenture surged 18% after beating fiscal fourth-quarter expectations with revenue of $18.7 billion. United Therapeutics gained 6% after a Delaware federal court ruled that Liquidia’s lung treatment infringed one of its patents, sending Liquidia down 15%. Synopsys climbed more than 8% during an investor day, guiding for 2027 revenue of $11.1 to $11.2 billion and announcing a strategic partnership with OpenAI. Vicor rose nearly 10% after raising its third-quarter revenue growth guidance to more than 30%. Corteva plunged 84% following the spinoff of its Vylor seed and genetics business.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
